$EXPI
EXP World Holdings, Inc.

2021 Q2 Form 10-Q Financial Statement

#000155837021010099 Filed on August 04, 2021

View on sec.gov

Income Statement

Concept 2021 Q2 2020 Q2 2020 Q1
Revenue $999.9M $353.5M $271.4M
YoY Change 182.83% 32.55% 72.84%
Cost Of Revenue $920.0M $319.2M $243.4M
YoY Change 188.21% 30.5% 70.81%
Gross Profit $79.92M $34.40M $28.00M
YoY Change 132.32% 55.66% 93.1%
Gross Profit Margin 7.99% 9.73% 10.32%
Selling, General & Admin $63.40M $26.04M $27.80M
YoY Change 143.47% 7.28% 34.97%
% of Gross Profit 79.34% 75.7% 99.3%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.517M $900.0K $757.0K
YoY Change 68.56% 80.0% 51.4%
% of Gross Profit 1.9% 2.62% 2.7%
Operating Expenses $983.4M $345.2M $271.2M
YoY Change 184.87% 28.4% 1216.55%
Operating Profit $16.51M $8.319M $211.0K
YoY Change 98.5% -485.67% -103.46%
Interest Expense -$1.000K $0.00 $0.00
YoY Change
% of Operating Profit -0.01% 0.0% 0.0%
Other Income/Expense, Net -$55.00K -$23.00K -$59.00K
YoY Change 139.13% -330.0% -41.0%
Pretax Income $16.46M $8.296M $152.0K
YoY Change 98.38% -486.4% -102.49%
Income Tax -$20.59M $61.00K $10.00K
% Of Pretax Income -125.08% 0.74% 6.58%
Net Earnings $37.05M $8.275M $165.0K
YoY Change 347.73% -476.99% -102.62%
Net Earnings / Revenue 3.71% 2.34% 0.06%
Basic Earnings Per Share $0.25 $0.06 $0.00
Diluted Earnings Per Share $0.24 $0.06 $0.00
COMMON SHARES
Basic Shares Outstanding 145.6M 135.5M 133.2M
Diluted Shares Outstanding 157.3M 145.1M 144.6M

Balance Sheet

Concept 2021 Q2 2020 Q2 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $107.4M $63.60M $44.30M
YoY Change 68.89% 101.9% 112.98%
Cash & Equivalents $107.4M $63.55M $44.28M
Short-Term Investments
Other Short-Term Assets $105.5M $20.70M $13.80M
YoY Change 409.51% 155.56% 130.0%
Inventory
Prepaid Expenses
Receivables $134.3M $52.54M $34.60M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $347.1M $136.8M $92.70M
YoY Change 153.75% 51.33% 64.07%
LONG-TERM ASSETS
Property, Plant & Equipment $11.17M $6.080M $7.000M
YoY Change 83.63% 48.29% 105.88%
Goodwill $12.95M $8.248M
YoY Change 56.95%
Intangibles $7.934M $2.837M
YoY Change 179.66%
Long-Term Investments
YoY Change
Other Assets $15.34M $0.00
YoY Change
Total Long-Term Assets $48.00M $18.07M $18.00M
YoY Change 165.59% 20.49% 27.66%
TOTAL ASSETS
Total Short-Term Assets $347.1M $136.8M $92.70M
Total Long-Term Assets $48.00M $18.07M $18.00M
Total Assets $395.1M $154.9M $110.7M
YoY Change 155.13% 46.94% 56.8%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.318M $1.642M $3.900M
YoY Change 284.77% -3.41% 200.0%
Accrued Expenses $119.6M $53.84M $37.70M
YoY Change 122.15% -0.11% 22.4%
Deferred Revenue $93.76M $17.41M
YoY Change 438.71%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $916.0K $970.0K $1.000M
YoY Change -5.57% -3.0% 0.0%
Total Short-Term Liabilities $220.9M $74.58M $52.40M
YoY Change 196.16% 18.76% 40.48%
LONG-TERM LIABILITIES
Long-Term Debt $1.716M $1.585M $1.600M
YoY Change 8.26% -11.94% -5.88%
Other Long-Term Liabilities $334.0K $200.0K $700.0K
YoY Change 67.0% 0.0% 250.0%
Total Long-Term Liabilities $1.716M $1.585M $2.300M
YoY Change 8.26% -20.75% 21.05%
TOTAL LIABILITIES
Total Short-Term Liabilities $220.9M $74.58M $52.40M
Total Long-Term Liabilities $1.716M $1.585M $2.300M
Total Liabilities $222.9M $76.34M $54.90M
YoY Change 192.02% 17.81% 40.05%
SHAREHOLDERS EQUITY
Retained Earnings $2.734M -$61.85M
YoY Change -104.42%
Common Stock $1.000K $1.000K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares $4.725M $2.048M $1.917M
Shareholders Equity $171.2M $78.33M $55.80M
YoY Change
Total Liabilities & Shareholders Equity $395.1M $154.9M $110.7M
YoY Change 155.13% 46.94% 56.8%

Cashflow Statement

Concept 2021 Q2 2020 Q2 2020 Q1
OPERATING ACTIVITIES
Net Income $37.05M $8.275M $165.0K
YoY Change 347.73% -476.99% -102.62%
Depreciation, Depletion And Amortization $1.517M $900.0K $757.0K
YoY Change 68.56% 80.0% 51.4%
Cash From Operating Activities $88.53M $28.50M $17.49M
YoY Change 210.61% 57.46% 161.03%
INVESTING ACTIVITIES
Capital Expenditures -$3.309M -$1.300M $1.355M
YoY Change 154.54% 0.0% -269.38%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities -$3.309M -$1.300M -$1.355M
YoY Change 154.54% 0.0% 4.23%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $10.31M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -54.54M -1.000M -8.390M
YoY Change 5353.6% -76.19% 146.76%
NET CHANGE
Cash From Operating Activities 88.53M 28.50M 17.49M
Cash From Investing Activities -3.309M -1.300M -1.355M
Cash From Financing Activities -54.54M -1.000M -8.390M
Net Change In Cash 30.68M 26.20M 7.034M
YoY Change 17.1% 107.94% 251.7%
FREE CASH FLOW
Cash From Operating Activities $88.53M $28.50M $17.49M
Capital Expenditures -$3.309M -$1.300M $1.355M
Free Cash Flow $91.83M $29.80M $16.13M
YoY Change 208.17% 53.61% 115.12%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Entity Central Index Key
EntityCentralIndexKey
0001495932
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
CY2021Q2 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2020Q4 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2021Q2 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2020Q4 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2021Q2 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
CY2020Q4 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0
CY2020 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0
CY2020 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-38493
dei Entity Registrant Name
EntityRegistrantName
EXP WORLD HOLDINGS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-0681092
dei Entity Address Address Line1
EntityAddressAddressLine1
2219 Rimland Drive, Suite 301
dei Entity Address City Or Town
EntityAddressCityOrTown
Bellingham
dei Entity Address State Or Province
EntityAddressStateOrProvince
WA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
98226
dei City Area Code
CityAreaCode
360
dei Local Phone Number
LocalPhoneNumber
685-4206
dei Security12b Title
Security12bTitle
Common Stock, par value $0.00001 per share
dei Trading Symbol
TradingSymbol
EXPI
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
146421690
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
107413000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
100143000
CY2021Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
93762000
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
27781000
CY2021Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1671000
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1879000
CY2021Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
134250000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
76951000
CY2021Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
11707000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7350000
CY2021Q2 us-gaap Assets Current
AssetsCurrent
347132000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
212225000
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11165000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7848000
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
622000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
819000
CY2021Q2 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
7000
CY2021Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
7934000
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
8350000
CY2021Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
15329000
CY2021Q2 us-gaap Goodwill
Goodwill
12945000
CY2020Q4 us-gaap Goodwill
Goodwill
12945000
CY2021Q2 us-gaap Assets
Assets
395134000
CY2020Q4 us-gaap Assets
Assets
242187000
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
6318000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3957000
CY2021Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
93762000
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
27781000
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
119605000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
62750000
CY2021Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
916000
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
1416000
CY2021Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
286000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
746000
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
220887000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
96650000
CY2021Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1716000
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2876000
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
334000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
74000
CY2021Q2 us-gaap Liabilities
Liabilities
222937000
CY2020Q4 us-gaap Liabilities
Liabilities
99600000
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
220000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
220000000
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
151146986
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
146421690
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
146677786
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
144143292
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
1000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
1000
CY2021Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
295035000
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
218492000
CY2021Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
4725296
CY2020Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
2534494
CY2021Q2 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
126906000
CY2020Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
37994000
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2734000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-39162000
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Before Tax1
AccumulatedOtherComprehensiveIncomeLossBeforeTax1
318000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Before Tax1
AccumulatedOtherComprehensiveIncomeLossBeforeTax1
247000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
171182000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
141584000
CY2021Q2 us-gaap Minority Interest
MinorityInterest
1015000
CY2020Q4 us-gaap Minority Interest
MinorityInterest
1003000
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
172197000
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
142587000
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
395134000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
242187000
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
999887000
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
353525000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1583720000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
624946000
CY2021Q2 expi Commissions And Other Agent Related Costs
CommissionsAndOtherAgentRelatedCosts
919970000
CY2020Q2 expi Commissions And Other Agent Related Costs
CommissionsAndOtherAgentRelatedCosts
319164000
expi Commissions And Other Agent Related Costs
CommissionsAndOtherAgentRelatedCosts
1450317000
expi Commissions And Other Agent Related Costs
CommissionsAndOtherAgentRelatedCosts
562570000
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
60721000
CY2020Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
25155000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
107021000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
52015000
CY2021Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2683000
CY2020Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
887000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4940000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1831000
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
983374000
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
345206000
us-gaap Operating Expenses
OperatingExpenses
1562278000
us-gaap Operating Expenses
OperatingExpenses
616416000
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
16513000
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
8319000
us-gaap Operating Income Loss
OperatingIncomeLoss
21442000
us-gaap Operating Income Loss
OperatingIncomeLoss
8530000
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-54000
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-11000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
80000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-49000
CY2021Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1000
CY2020Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-12000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-7000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-34000
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-55000
CY2020Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-23000
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.24
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
73000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-83000
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
16458000
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
8296000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
21515000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
8447000
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-20585000
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
61000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-20374000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
70000
CY2021Q2 us-gaap Profit Loss
ProfitLoss
37043000
CY2020Q2 us-gaap Profit Loss
ProfitLoss
8235000
us-gaap Profit Loss
ProfitLoss
41889000
us-gaap Profit Loss
ProfitLoss
8377000
CY2021Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-7000
CY2020Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-40000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-7000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-63000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
37050000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
8275000
us-gaap Net Income Loss
NetIncomeLoss
41896000
us-gaap Net Income Loss
NetIncomeLoss
8440000
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.25
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.29
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.27
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
145584495
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
135511932
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
144973139
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
133502272
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
157288672
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
145124056
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
158096735
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
143901821
CY2021Q2 us-gaap Profit Loss
ProfitLoss
37043000
CY2020Q2 us-gaap Profit Loss
ProfitLoss
8235000
us-gaap Profit Loss
ProfitLoss
41889000
us-gaap Profit Loss
ProfitLoss
8377000
CY2021Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-7000
CY2020Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-40000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-7000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-63000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
37050000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
8275000
us-gaap Net Income Loss
NetIncomeLoss
41896000
us-gaap Net Income Loss
NetIncomeLoss
8440000
expi Amortization Expense Related To Discount Applied In Business Combination
AmortizationExpenseRelatedToDiscountAppliedInBusinessCombination
107000
us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
-208000
us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
1123000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-7000
CY2021Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
24000
CY2020Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
244000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
71000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-53000
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
37074000
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
8519000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
41967000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
8387000
CY2021Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
24000
CY2020Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
244000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
71000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-53000
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
172197000
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
78532000
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
172197000
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
78532000
us-gaap Profit Loss
ProfitLoss
41889000
us-gaap Profit Loss
ProfitLoss
8377000
us-gaap Depreciation
Depreciation
2196000
us-gaap Depreciation
Depreciation
1551000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
621000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
230000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-34000
expi Share Based Compensation Agent Growth Incentive Programs
ShareBasedCompensationAgentGrowthIncentivePrograms
11312000
expi Share Based Compensation Agent Growth Incentive Programs
ShareBasedCompensationAgentGrowthIncentivePrograms
6765000
us-gaap Share Based Compensation
ShareBasedCompensation
6239000
us-gaap Share Based Compensation
ShareBasedCompensation
2300000
expi Share Based Compensation Agent Equity Program
ShareBasedCompensationAgentEquityProgram
59853000
expi Share Based Compensation Agent Equity Program
ShareBasedCompensationAgentEquityProgram
19297000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-15329000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
57095000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
25471000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
4466000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-318000
us-gaap Increase Decrease In Deposits Outstanding
IncreaseDecreaseInDepositsOutstanding
-65981000
us-gaap Increase Decrease In Deposits Outstanding
IncreaseDecreaseInDepositsOutstanding
-10418000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2354000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-951000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
54231000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
21938000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-160000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
167425000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
46036000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5609000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2273000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
1500000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7109000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2687000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
88912000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
389000
expi Other Investing Activities
OtherInvestingActivities
25000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
11987000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1757000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2467000
us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
19000
us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
106000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-87136000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-9414000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
71000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-53000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
73251000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
33882000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
127924000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
47074000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
201175000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
80956000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
702000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
224000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
18000
expi Lease Termination Non Cash Investing And Financing Activities
LeaseTerminationNonCashInvestingAndFinancingActivities
120000
expi Lease Termination Non Cash Investing And Financing Activities
LeaseTerminationNonCashInvestingAndFinancingActivities
183000
expi Property Plant And Equipment Purchases In Accounts Payable
PropertyPlantAndEquipmentPurchasesInAccountsPayable
7000
expi Property Plant And Equipment Purchases In Accounts Payable
PropertyPlantAndEquipmentPurchasesInAccountsPayable
24000
us-gaap Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
On January 15, 2021, the Company’s Board of Directors approved a two-for-one stock split in the form of a stock dividend to stockholders of record as of January 29, 2021 (the “Stock Split”). The Stock Split was effected on February 12, 2021.
CY2021Q1 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
2
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><span style="font-style:italic;font-weight:bold;">Use of Estimate</span>s</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 6pt 0pt;">assumptions related to allowance for credit losses, legal contingencies, income taxes, revenue recognition, stock-based compensation, goodwill, and deferred income tax asset valuation allowances. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.</p>
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><span style="font-style:italic;font-weight:bold;">Reclassifications</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 6pt 0pt;">When necessary, the Company will reclassify certain amounts in prior-period financial statements to conform to the current period’s presentation. No material reclassifications occurred during the current period.</p>
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
40087000
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
6987000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
47074000
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
63551000
CY2020Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
17405000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
80956000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
100143000
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
27781000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
127924000
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
107413000
CY2021Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
93762000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
201175000
CY2021Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
318000
CY2020Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
126000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
621000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
230000
CY2021Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
0
CY2021Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1671000
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1879000
CY2021Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
17600000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
13848000
CY2021Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
8931000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6738000
CY2021Q2 expi Property Plant And Equipment Excluding Assets Under Construction
PropertyPlantAndEquipmentExcludingAssetsUnderConstruction
8669000
CY2020Q4 expi Property Plant And Equipment Excluding Assets Under Construction
PropertyPlantAndEquipmentExcludingAssetsUnderConstruction
7110000
CY2021Q2 expi Assets Under Development
AssetsUnderDevelopment
2496000
CY2020Q4 expi Assets Under Development
AssetsUnderDevelopment
738000
CY2021Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
9535000
CY2021Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1601000
CY2021Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
7934000
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
9330000
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
980000
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
8350000
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11165000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7848000
CY2021Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1189000
CY2020Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
794000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2196000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1551000
CY2021Q2 us-gaap Goodwill
Goodwill
12945000
CY2020Q4 us-gaap Goodwill
Goodwill
12945000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2021Q2 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2021Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
84000
CY2020Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
104000
us-gaap Operating Lease Cost
OperatingLeaseCost
202000
us-gaap Operating Lease Cost
OperatingLeaseCost
208000
CY2021Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
10000
CY2020Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
5000
us-gaap Short Term Lease Cost
ShortTermLeaseCost
26000
us-gaap Short Term Lease Cost
ShortTermLeaseCost
10000
CY2021Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
84000
CY2020Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
107000
us-gaap Operating Lease Payments
OperatingLeasePayments
202000
us-gaap Operating Lease Payments
OperatingLeasePayments
204000
CY2021Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y7M6D
CY2020Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y8M12D
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
4400578
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
151146986
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
141160576
CY2021Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y7M6D
CY2020Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y8M12D
CY2021Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.04855
CY2020Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.04851
CY2021Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.04855
CY2020Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.04851
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
181000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
309000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
159000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
0
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
0
CY2021Q2 expi Lessee Operating Lease Liability Payments Due Year Five And After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndAfterYearFive
0
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
649000
CY2021Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
29000
CY2021Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
620000
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
147934768
CY2020Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
138056230
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
146677786
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
132398616
CY2021Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1797132
CY2020Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
830482
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
2344908
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
37050000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
8275000
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
151146986
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
141160576
CY2020Q4 expi Stock Compensation Liability Activity
StockCompensationLiabilityActivity
2093000
CY2021Q1 expi Increase Decrease In Stock Grant Liability
IncreaseDecreaseInStockGrantLiability
1221000
CY2021Q2 expi Increase Decrease In Stock Grant Liability
IncreaseDecreaseInStockGrantLiability
1402000
CY2021Q2 expi Stock Compensation Liability Activity
StockCompensationLiabilityActivity
4716000
CY2018Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
25000000.0
CY2020Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
75000000.0
CY2020Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
75000000.0
CY2020Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
400000000.0
CY2021Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
3035404
CY2020Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
1916605
CY2020Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
2534494
CY2019Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
925364
CY2021Q2 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
1689892
CY2020Q2 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
131173
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
2190802
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
1122414
CY2021Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
4725296
CY2020Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
2047778
CY2021Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
4725296
CY2020Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
2047778
us-gaap Net Income Loss
NetIncomeLoss
41896000
us-gaap Net Income Loss
NetIncomeLoss
8440000
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
145584495
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
135511932
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
144973139
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
133502272
CY2021Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
11704177
CY2020Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
9612124
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
13123596
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
10399549
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
157288672
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
145124056
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
158096735
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
143901821
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.25
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.29
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.24
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.27
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
CY2021Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
152950
CY2020Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
821985
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
62889
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
803513
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-20400000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.951
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.008
us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-13000000
CY2021Q2 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2020Q4 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1

Files In Submission

Name View Source Status
0001558370-21-010099-index-headers.html Edgar Link pending
0001558370-21-010099-index.html Edgar Link pending
0001558370-21-010099.txt Edgar Link pending
0001558370-21-010099-xbrl.zip Edgar Link pending
expi-20210630.xsd Edgar Link pending
expi-20210630x10q.htm Edgar Link pending
expi-20210630x10q001.jpg Edgar Link pending
expi-20210630x10q_htm.xml Edgar Link completed
expi-20210630xex31d1.htm Edgar Link pending
expi-20210630xex31d2.htm Edgar Link pending
expi-20210630xex32d1.htm Edgar Link pending
expi-20210630xex32d2.htm Edgar Link pending
expi-20210630xex3d1.htm Edgar Link pending
expi-20210630_cal.xml Edgar Link unprocessable
expi-20210630_def.xml Edgar Link unprocessable
expi-20210630_lab.xml Edgar Link unprocessable
expi-20210630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending